Integrative determination of atomic structure of mutant huntingtin exon 1 fibrils implicated in Huntington disease, 2024, Helabad et al

Wyva

Senior Member (Voting Rights)
Mahdi Bagherpoor Helabad, Irina Matlahov, Raj Kumar, Jan O. Daldrop, Greeshma Jain, Markus Weingarth, Patrick C. A. van der Wel & Markus S. Miettinen

Abstract

Neurodegeneration in Huntington’s disease (HD) is accompanied by the aggregation of fragments of the mutant huntingtin protein, a biomarker of disease progression. A particular pathogenic role has been attributed to the aggregation-prone huntingtin exon 1 (HTTex1), generated by aberrant splicing or proteolysis, and containing the expanded polyglutamine (polyQ) segment.

Unlike amyloid fibrils from Parkinson’s and Alzheimer’s diseases, the atomic-level structure of HTTex1 fibrils has remained unknown, limiting diagnostic and treatment efforts. We present and analyze the structure of fibrils formed by polyQ peptides and polyQ-expanded HTTex1 in vitro.

Atomic-resolution perspectives are enabled by an integrative analysis and unrestrained all-atom molecular dynamics (MD) simulations incorporating experimental data from electron microscopy (EM), solid-state NMR, and other techniques. Alongside the use of prior data, we report magic angle spinning NMR studies of glutamine residues of the polyQ fibril core and surface, distinguished via hydrogen-deuterium exchange (HDX). Our study provides a molecular understanding of the structure of the core as well as surface of aggregated HTTex1, including the fuzzy coat and polyQ–water interface.

The obtained data are discussed in context of their implications for understanding the detection of such aggregates (diagnostics) as well as known biological properties of the fibrils.

Open access: https://www.nature.com/articles/s41467-024-55062-8
 
Thank you for posting, Wyva!

According to the researchers, they’ve developed some new techniques and everything is available for anyone.
"We use advanced computer simulations to mimic the behavior of these molecules as realistically as possible. Our work bridges the gap between simulations and experiments, providing insights into data that are otherwise difficult to interpret. Beyond the new insights into Huntington's disease, we have developed tools that make molecular simulations more accessible to researchers worldwide," says Miettinen.
https://medicalxpress.com/news/2025-01-simulations-protein-clumps-linked-huntington.html
 
Back
Top Bottom